Designs and delivers srRNA immunotherapies to prevent drug resistance in cancer using proprietary synthetic immune lethality technology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Replicate Bioscience is designing and delivering srRNA immunotherapies to revolutionize the practice of medicine and improve and save lives. Replicate applies advanced srRNA technology in its work to prevent drug resistance in cancers; this is the company’s proprietary synthetic immune lethality approach.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Replicate Bioscience Management Team
Investors
Apple Tree Partners
Replicate Bioscience Valuations & Financials
View real-time NPM data on Replicate Bioscience stock including daily Replicate Bioscience stock price estimates, valuation history, and historical share price information. Access Replicate Bioscience financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Replicate Bioscience pricing across six independent market signals. Looking for private company due diligence data sources on Replicate Bioscience? Get in touch to learn more.
Similar Companies
like Replicate Bioscience
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Octave Bioscience
Healthcare & Life Sciences
Provides data-driven disease activity insights for precision neurology.
Strike Graph
Cybersecurity
Develops AI-driven compliance software that automates security audits and helps organizations meet regulatory standards.
CirrusMD
Healthcare & Life Sciences
Connects users to live physician guidance via chat‑first virtual care integrated with benefit navigation.
Shriji Polymers
Climate & Sustainability
Manufactures high-quality plastic and polymer products, specializing in sustainable packaging solutions for industrial applications.
Nucs Ai
Healthcare & Life Sciences
Provides clinicians imaging data with outcome predictions for PSMA-targeted therapies and tumor burden quantification.
Effect Photonics
Enterprise Software
Enable high‑speed communication and precision sensing for next‑generation systems.
Vyrl
Media & Entertainment
Connects brands and creators through a curated influencer network that enables collaborations, content, and commerce in one seamless hub.
Sleeper
Media & Entertainment
A digital platform that offers fantasy sports games, allowing users to draft, manage teams, and compete with friends.
FAQ
We have answers
Replicate Bioscience stock does not trade on public stock exchanges. Replicate Bioscience stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Replicate Bioscience stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Replicate Bioscience Stock does not trade on public stock exchanges. In order to sell Replicate Bioscience shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Replicate Bioscience does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Replicate Bioscience share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Replicate Bioscience stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Replicate Bioscience stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Replicate Bioscience stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Replicate Bioscience is a private company and has not had an IPO. There is currently no Replicate Bioscience IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Replicate Bioscience IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
